Crossmark

Efficacy and Safety of Ultra-Rapid Lispro in Younger and Older Patients with Type 2 Diabetes: Randomized Double-Blind PRONTO-T2D Study

Published Online: 2022-07-04

Published Print: 2022-08

Authors

Zhang, Qianyi

Chigutsa, Farai

Chang, Annette M. https://orcid.org/0000-0003-0847-0333
Funding

Funding for this research was provided by:

Eli Lilly and Company
License Information

Text and Data Mining valid from 2022-07-04

Version of Record valid from 2022-07-04
More Information

Article History

Received: 26 April 2022

Accepted: 14 June 2022

First Online: 4 July 2022

Document is current